Field cancerization profile-based prognosis signatures lead to more robust risk evaluation in hepatocellular carcinoma

The development of reliable biomarkers has been an urgent issue as well as a hot spot of research on the diagnosis, treatment, and prognostic evaluation of hepatocellular carcinoma (HCC). Here, we established and validated two field cancerization profile-based prognostic signatures (gene expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lu, Songyang, Zhou, Dai, Zhiming, Xiong, Yuanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800113/
https://www.ncbi.nlm.nih.gov/pubmed/35118360
http://dx.doi.org/10.1016/j.isci.2022.103747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800113/
https://www.ncbi.nlm.nih.gov/pubmed/35118360
http://dx.doi.org/10.1016/j.isci.2022.103747

Ejemplares similares